Stem Cells

HighQC™ Human (Parental) Prostate Cancer Stem Cell

  • For research use only

Cat No.

ABC-SC0121

Product Type

Human Cancer Stem Cells

Cell Type

Stem Cell

Species

Human

Growth Conditions

37 ℃, 5% CO2

Source Organ

Prostate

Disease

Prostate Cancer

Storage

Liquid Nitrogen

Human (Parental) Prostate Cancer Stem Cell; Frozen Vial and Plated cells are available.

Product Image

Description

HighQC™ Human (Parental) Prostate Cancer Stem Cells are a rare and highly tumorigenic population derived from primary human prostate carcinoma tissues. Morphologically, they exhibit a small, round or slightly elongated shape. These cells represent prostate cancer stem cells (PCSCs), characterized by their self-renewal ability, long-term proliferation, and potential to generate heterogeneous tumor cell populations. These cells express key PCSC markers, including CD44 and CD133. They exhibit self-renewal, generate heterogeneous prostate cancer cell populations in vitro, and initiate tumors in xenograft models. Each lot undergoes rigorous screening and isolation procedures, and is rigorously tested to ensure it is free of contamination from HIV-1, HBV, HCV, syphilis, mycoplasma, fungi, yeast, and bacteria.

Product Code

HighQC™ Human (Parental) Prostate Cancer Stem Cell, Human Parental PCSC, hPara-PCSC, Human Prostate Cancer Progenitors

Species

Human

Cat.No

ABC-SC0121

Product Category

Stem Cells

Size/Quantity

1 vial

Cell Type

Stem Cell

Growth Mode

Adherent

Shipping Info

Dry Ice

Growth Conditions

37 ℃, 5% CO2

Source Organ

Prostate

Disease

Prostate Cancer

Biosafety Level

1

Storage

Liquid Nitrogen

Product Type

Human Cancer Stem Cells

Application

  • HighQC™ Human (Parental) Prostate Cancer Stem Cells, also known as prostate tumor-initiating cells (TIC), are widely used to investigate cancer stem cell (CSC) biology, including mechanisms of dormancy, metastasis, and relapse. This Parental prostate CSC line exhibits the ability to form tumor spheroids in vitro and generate xenograft tumors in vivo, making them ideal for preclinical drug screening and enabling the evaluation of novel CSC-targeted therapies such as Wnt/β-catenin, Notch, or Hedgehog pathway inhibitors.

Citation

When you publish your research, please cite our product as "AcceGen Biotech Cat.# XXX-0000". In return, we’ll give you a $200 coupon. Simply click here and submit your paper’s PubMed ID (PMID).

Inquiring HighQC™ Human (Parental) Prostate Cancer Stem Cell

We know how valuable your research is to you, but are you wondering what you can expect to pay for quick accurate results every time? Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.
High Viability
To succeed in cell culture
Precision and Reliability
To support a consistent result
Customization Options
Tailed to your research

Tags

AcceGen Scroll Top Button